Cigna (CI)

Healthcare · Healthcare Plans · S&P 500
$278.95 +1.67% on the day Market cap $70.0B 52-week range $239.51 to $312.18 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Cigna's free cash flow isn't comparable to its market value here, so a cash-flow reverse DCF doesn't give a meaningful answer. The Modeling tab works from revenue and margins instead.

Fundamental grade

C

Five factors scored 1 to 9 from CI's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation9
Profitability5
Growth4
Financial health1

Key numbers

P/E (trailing)11.0x
P/E (forward)8.80x
Price / free cash flow8.35x
EV / EBITDA7.36x
Price / sales0.25x
Price / book1.67x
Revenue growth+6.7%
Operating margin3.5%
Net margin2.3%
Return on equity15.2%
Dividend yield2.2%
Debt / equity2.68x

Results from SEC filings

Fiscal years, from Cigna's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$174.1B$180.5B$195.3B$247.1B$274.9B
Net income$5.4B$6.7B$5.2B$3.4B$6.0B
Free cash flow—————
EPS (diluted)$15.75$21.41$17.39$12.12$22.18
Operating margin4.6%4.7%4.4%3.8%3.3%

Where the revenue comes from

Revenue by segments, fiscal 2025.

Evernorth Health Services$235.0B83%
Cigna Healthcare$47.4B17%
Other Operations$674M0%

Superinvestors who own CI

From each investor's latest 13F filing (what a 13F shows). 9 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Dodge & Cox
Dodge & Cox
Added $3.4B1.8%Q2 2026
Cliff Asness
AQR Capital Management
Trimmed $396M0.14%Q2 2026
Charles Brandes
Brandes Investment Partners, LP
Trimmed $232M1.6%Q2 2026
Andrew Wellington
Lyrical Asset Management
Trimmed $205M2.6%Q2 2026
Richard Pzena
Pzena Investment Management
Trimmed $155M0.46%Q2 2026
Larry Robbins
Glenview Capital Management
Trimmed $114M2.1%Q2 2026
Joel Greenblatt
Gotham Asset Management
Added $31M0.07%Q2 2026
Mario Gabelli
GAMCO Investors
Trimmed $3M0.02%Q2 2026
Tweedy, Browne
Tweedy, Browne Company
Added $2M0.16%Q2 2026

Insider buying

Open-market purchases by Cigna's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

DateInsiderSharesPriceValue
Feb 24, 2026 Ro Khanna
0$280.57—
Feb 24, 2026 Ro Khanna
0$280.57—
Feb 17, 2026 Ro Khanna
0$290.57—
Feb 17, 2026 Ro Khanna
0$290.57—
Jan 29, 2026 Ro Khanna
0$271.18—
Jan 29, 2026 Ro Khanna
0$271.18—
Jan 13, 2026 Ro Khanna
0$271.77—
Jan 13, 2026 Ro Khanna
0$271.77—
Dec 19, 2025 Gilbert Ray Cisneros, Jr.
0$272.11—
Dec 19, 2025 Gilbert Ray Cisneros, Jr.
0$272.11—

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when CI trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

Are Cigna insiders buying the stock?

10 open-market insider purchases of CI in the last 12 months, from SEC Form 4 filings.

Which superinvestors own Cigna?

9 of the superinvestors Investingly tracks hold CI in their latest 13F, including Dodge & Cox, Cliff Asness, Charles Brandes.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.